{"gene":"MAOA","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1995,"finding":"MAOA encodes a monoamine oxidase enzyme that degrades serotonin and norepinephrine in the brain; knockout mice lacking MAOA show up to 9-fold elevated brain serotonin and 2-fold elevated norepinephrine, demonstrating MAOA's essential role in monoamine catabolism. The behavioral phenotype (trembling, fearfulness, aggression) was reversed by the serotonin synthesis inhibitor parachlorophenylalanine, confirming serotonin elevation as the mechanistic driver.","method":"Transgenic knockout mouse model with neurochemical measurement (HPLC) and pharmacological rescue (parachlorophenylalanine)","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo KO with defined neurochemical phenotype, pharmacological rescue, replicated across the field","pmids":["7792602"],"is_preprint":false},{"year":1999,"finding":"MAO-A preferentially oxidizes serotonin (5-HT) and norepinephrine (NE), whereas MAO-B preferentially oxidizes phenylethylamine (PEA). MAO-A KO mice have elevated brain levels of 5-HT, NE, and DA and manifest aggression, while MAO-B KO mice show only elevated PEA without aggression, establishing distinct substrate specificities and physiological roles for the two isoforms.","method":"Homologous recombination KO mice with neurochemical profiling","journal":"Neurobiology (Budapest)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal KO models with distinct neurochemical and behavioral phenotypes","pmids":["10591056"],"is_preprint":false},{"year":2021,"finding":"MAO-A, but not MAO-B, is the primary enzyme responsible for striatal dopamine degradation in vivo, as shown by in vivo electrochemical monitoring and ex vivo fluorescence imaging. In contrast, MAO-B (not MAO-A) is responsible for astrocytic GABA synthesis mediating tonic inhibitory currents in the rat striatum.","method":"In vivo fast-scan cyclic voltammetry, multiple-cyclic square wave voltammetry, ex vivo GRABDA2m fluorescence imaging, and whole-cell patch-clamp electrophysiology","journal":"Experimental & Molecular Medicine","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal in vivo and ex vivo methods with selective inhibitors distinguishing MAO-A vs MAO-B contributions","pmids":["34244591"],"is_preprint":false},{"year":2021,"finding":"MAOA promotes prostate cancer perineural invasion by activating SEMA3C transcription in a Twist1-dependent manner; SEMA3C then stimulates cMET via autocrine/paracrine interaction with co-activated PlexinA2 and NRP1 receptors to facilitate invasion.","method":"In vitro PNI assay, orthotopic xenograft model, gene silencing, mechanistic pathway analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo models with defined pathway (Twist1→SEMA3C→PlexinA2/NRP1→cMET) and functional rescue","pmids":["33420365"],"is_preprint":false},{"year":2021,"finding":"MAOA and androgen receptor (AR) form a positive feedback loop in prostate cancer: androgens induce MAOA transcription via direct AR binding to a novel intronic androgen response element, and MAOA in turn promotes AR transcriptional activity through upregulation of Shh/Gli-YAP1 signaling and nuclear YAP1-AR interactions.","method":"ChIP assay (AR binding to MAOA intronic element), gene silencing, xenograft mouse models, co-immunoprecipitation, luciferase reporter assays","journal":"Cancer Research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including ChIP, co-IP, reporter assays, and in vivo validation","pmids":["34167949"],"is_preprint":false},{"year":2020,"finding":"MAOA in stromal fibroblasts elevates reactive oxygen species production, triggers IL-6 activation through direct Twist1 binding to a conserved E-box element in the IL-6 promoter, and promotes prostate cancer cell growth via paracrine IL-6/STAT3 signaling. STAT3 then transcriptionally activates CD44 to promote cancer stemness.","method":"ChIP assay (Twist1 binding to IL-6 promoter E-box), co-culture systems, in vivo xenograft, tissue microarray, gene silencing","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — ChIP-validated transcriptional mechanism with in vivo confirmation and clinical tissue correlation","pmids":["32066880"],"is_preprint":false},{"year":2018,"finding":"Prostate-specific deletion of MAOA in a Pten-KO mouse model significantly reduced prostate cancer incidence, AKT phosphorylation, Ki67 expression, and cancer stem cell markers (OCT4, NANOG, CD44, α2β1, CD133, HIF-1α), establishing that MAOA promotes adenocarcinoma development by supporting cell proliferation and maintenance of cancer stem cells through the PTEN/AKT axis.","method":"Conditional Pten/MAOA double-KO mouse model, shRNA knockdown, colony/spheroid formation assays, MAOA inhibitor treatment","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with multiple mechanistic readouts and pharmacological validation","pmids":["29844571"],"is_preprint":false},{"year":2015,"finding":"Cancer-associated fibroblasts (CAFs) induce prostate cancer cell EMT and invasion through a MAOA/mTOR/HIF-1α signaling pathway that exploits reactive oxygen species (ROS). Curcumin abrogated CAF-induced invasion by inhibiting this MAOA/mTOR/HIF-1α pathway and reducing ROS production.","method":"In vitro invasion assays, ROS measurement, pathway inhibition, siRNA knockdown","journal":"International Journal of Oncology","confidence":"Medium","confidence_rationale":"Tier 3 — in vitro mechanistic pathway analysis without full genetic rescue or in vivo validation of pathway order","pmids":["26499200"],"is_preprint":false},{"year":2017,"finding":"MAOA is a direct target gene of the transcriptional repressor REST. ROS produced by overexpressed MAOA inhibits apoptosis and activates autophagy in neuroendocrine-differentiated prostate cancer cells, placing MAOA downstream of REST and upstream of the autophagy/apoptosis decision.","method":"ChIP, luciferase reporter assay, ROS measurement, MAOA overexpression/inhibition, autophagy/apoptosis assays","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-validated REST→MAOA regulation with functional ROS/autophagy mechanistic follow-up","pmids":["28402333"],"is_preprint":false},{"year":2019,"finding":"MAOA inhibitors (clorgyline and phenelzine) decrease MAOA enzymatic activity in prostate cancer cells, suppress proliferation, and clorgyline decreases expression of both full-length AR and AR splice variant 7 (AR-V7), with additive growth inhibition when combined with enzalutamide.","method":"MAOA activity assay, cell viability assay, Western blot for AR/AR-V7, enzalutamide-resistant cell line model","journal":"The Prostate","confidence":"Medium","confidence_rationale":"Tier 2 — direct enzyme activity measurement combined with defined molecular endpoint (AR/AR-V7 reduction) in multiple cell line contexts","pmids":["30693539"],"is_preprint":false},{"year":2012,"finding":"Methylation of the MAOA promoter CpG region (measured in blood cells) is robustly associated with brain MAO-A activity levels as measured by PET, and the VNTR genotype does not independently predict brain MAO-A activity, suggesting promoter methylation is a key epigenetic regulator of MAOA expression and activity.","method":"Bisulfite sequencing of MAOA promoter from blood DNA combined with [(11)C]clorgyline PET imaging of brain MAO-A activity in healthy males","journal":"Epigenetics","confidence":"High","confidence_rationale":"Tier 2 — two orthogonal methods (epigenetic sequencing + PET quantification) with robust association linking blood methylation to brain enzyme activity","pmids":["22948232"],"is_preprint":false},{"year":2018,"finding":"MAOA promoter methylation is functionally relevant: methylated MAOA promoter constructs show decreased reporter gene activity compared to unmethylated constructs. Methylation levels increase after exposure therapy for acrophobia and correlate with treatment response, demonstrating dynamic, functionally relevant epigenetic regulation of MAOA.","method":"Bisulfite sequencing of blood DNA before/after therapy, luciferase-based reporter gene assay with methylated vs. unmethylated constructs","journal":"International Journal of Neuropsychopharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — functional reporter assay demonstrates mechanistic link between methylation and transcription, with in vivo correlation","pmids":["30169842"],"is_preprint":false},{"year":2012,"finding":"Acute psychosocial stress and acute glucocorticoid (dexamethasone) exposure rapidly decrease MAO-A activity and protein levels in neuronal and glial cell lines, and reduce MAO-A binding in 10 of 11 brain regions by PET, establishing a convergent regulatory mechanism whereby acute stress/glucocorticoids suppress MAOA expression.","method":"[(11)C]harmine PET in humans under acute stress; Western blot and [(14)C]-5-HT metabolism assay in human neuronal/glial cell lines after dexamethasone","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — convergent human PET imaging and in vitro biochemical assays with direct activity and protein measurements","pmids":["23197705"],"is_preprint":false},{"year":2018,"finding":"IL-6/IL-6R signaling inhibits MAO-A activity and expression in hypoxic breast cancer cells; reciprocally, elevated MAO-A suppresses tumor angiogenesis and invasion. Inhibition of IL-6R or siRNA knockdown of IL-6R increased MAO-A activity and inhibited VEGF, MMPs, and EMT markers, placing MAO-A downstream of IL-6R and upstream of the pro-tumorigenic ROS pathway.","method":"In vitro siRNA knockdown, IL-6R inhibitor treatment, MAO-A activity assay, invasion/angiogenesis assays, in vivo tumor models, clinical specimen IHC","journal":"British Journal of Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro and in vivo methods establishing IL-6R→MAO-A regulatory relationship with functional angiogenesis/invasion readouts","pmids":["29695771"],"is_preprint":false},{"year":2018,"finding":"IL-13 stimulates MAOA gene expression and enzymatic activity in primary human monocytes and A549 lung carcinoma cells through a pathway involving STAT1/3/6, EGR1, CREB, and 15-lipoxygenase (15-LO); 15-LO then drives MAOA expression via PPARγ in a STAT6-dependent manner. This IL-13-STAT6-15-LO-PPARγ axis controls MAOA-dependent ROS generation and cell migration.","method":"siRNA knockdown, selective inhibitors, qPCR, MAOA activity assay, ROS measurement, migration assay in primary monocytes and cancer cells","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — systematic pathway dissection with siRNA and inhibitors, activity assays, and functional readouts across two cell types","pmids":["30021838"],"is_preprint":false},{"year":2023,"finding":"MAOA interacts physically with NDRG1 and suppresses glycolysis/Warburg effect in gastric cancer cells through inhibition of the PI3K/AKT/mTOR pathway; loss of MAOA facilitates gastric cancer progression.","method":"Co-immunoprecipitation (MAOA-NDRG1 interaction), Western blot for PI3K/AKT/mTOR, Seahorse metabolic assay, siRNA knockdown, in vivo mouse model","journal":"Cellular Oncology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP validates physical interaction; Seahorse and pathway analysis establish metabolic mechanism","pmids":["37249744"],"is_preprint":false},{"year":2019,"finding":"Systematic meta-analysis confirmed that the MAOA 5' VNTR polymorphism has a robust and medium-to-large effect on MAOA enzyme activity, establishing this promoter variant as a functional regulatory polymorphism that determines the level of MAO-A protein activity.","method":"Systematic review and meta-analysis of studies measuring polymorphism effects on enzyme expression, abundance, and activity","journal":"Biological Psychiatry","confidence":"High","confidence_rationale":"Tier 1-2 — meta-analysis of multiple functional studies with enzyme activity as the direct endpoint; strong preponderance of evidence","pmids":["31303260"],"is_preprint":false},{"year":2006,"finding":"MAOA is subject to X chromosome inactivation in human female fibroblasts, resulting in monoallelic expression; this was demonstrated using primary clonal cell cultures with RFLP-based allelic expression analysis.","method":"Primary clonal cell culture, RFLP allelic expression analysis","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2 — direct allele-specific expression assay in primary human cells","pmids":["16890910"],"is_preprint":false},{"year":2009,"finding":"MAOA is subject to X chromosome inactivation (not escape) in normal human fibroblasts, with monoallelic expression confirmed by allele-specific expression analysis combined with promoter DNA methylation profiling in cells with skewed X inactivation.","method":"Allele-specific expression using skewed X-inactivation fibroblasts, methylation analysis of MAOA 5' end","journal":"Epigenetics","confidence":"Medium","confidence_rationale":"Tier 2 — two complementary methods (expression + methylation) in normal human cells, confirming XCI status","pmids":["19684479"],"is_preprint":false},{"year":1990,"finding":"In situ hybridization histochemistry showed that locus coeruleus neurons in human brain express MAO-A mRNA, while raphe neurons express MAO-B mRNA, establishing a neuroanatomical basis for the distinct functional roles of the two isoforms.","method":"In situ hybridization histochemistry combined with enzyme radioautography in human post-mortem brain","journal":"Journal of Neural Transmission (Supplementum)","confidence":"Medium","confidence_rationale":"Tier 2 — direct cellular localization of mRNA in human brain with histochemical validation","pmids":["2089112"],"is_preprint":false},{"year":2012,"finding":"ApoE4 isoform expression in C6 glioma cells reduces MAOA mRNA expression compared to ApoE3, resulting in elevated serotonin (substrate for MAOA) and consequently increased melatonin biosynthesis, establishing a regulatory link between ApoE genotype and MAOA expression levels.","method":"Stable ApoE isoform expression in C6 cells, melatonin ELISA, Western blot, qRT-PCR of MAOA/MAOB","journal":"Journal of Pineal Research","confidence":"Low","confidence_rationale":"Tier 3 — single cell line model, indirect pathway inference, no direct MAOA enzymatic activity measured","pmids":["22225631"],"is_preprint":false},{"year":2025,"finding":"Inhibition of stromal MAOA increases WNT5A production in cancer-associated fibroblasts, which activates CD8+ T cell cytotoxic capacity through the Ca2+-NFATC1 signaling pathway, identifying a mechanism by which stromal MAOA suppresses anti-tumor immunity in prostate cancer.","method":"Single-cell sequencing reanalysis, in vitro co-culture of stromal and immune cells, subcutaneous and humanized mouse models, MAOA inhibitor + immune checkpoint inhibitor combination","journal":"Journal for Immunotherapy of Cancer","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo mechanistic data with defined pathway (MAOA inhibition→WNT5A→Ca2+-NFATC1→CD8+ T cell activation)","pmids":["40121032"],"is_preprint":false},{"year":2023,"finding":"TPhP (triphenyl phosphate) activates MAOA in trophoblast cells, leading to increased ROS production that activates NFκB, which in turn disrupts tryptophan metabolism by inhibiting the tryptophan-serotonin pathway and activating the kynurenine pathway. MAOA inhibitor clorgyline or antioxidant N-acetylcysteine mitigated these effects.","method":"JEG-3 trophoblast cell line treatment, MAOA inhibitor (clorgyline) and NFκB inhibitor (sulfasalazine) rescue experiments, ROS assay, qPCR, Western blot; mouse intrauterine exposure model","journal":"Science of the Total Environment","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibition experiments with multiple pathway markers establish MAOA→ROS→NFκB→tryptophan metabolism axis","pmids":["37659542"],"is_preprint":false}],"current_model":"MAOA is a mitochondrial flavoenzyme that oxidatively deaminates monoamine neurotransmitters (preferentially serotonin and norepinephrine, and dopamine in the striatum), generating H2O2 as a byproduct; its expression is regulated by promoter VNTR polymorphism and CpG methylation (which functionally suppresses transcription), by glucocorticoid/acute stress exposure (acutely downregulating activity), by IL-13 via a STAT6-15-LO-PPARγ axis, and by androgens through direct AR binding to an intronic response element; in prostate cancer it drives a reciprocal feedback loop with AR (via Shh/Gli-YAP1), promotes stromal IL-6/STAT3 paracrine signaling through Twist1-dependent transcription, mediates perineural invasion via SEMA3C/PlexinA2/NRP1-cMET, and suppresses anti-tumor immunity by limiting stromal WNT5A-Ca2+-NFATC1-CD8+ T cell activation."},"narrative":{"teleology":[{"year":1990,"claim":"Establishing the neuroanatomical expression pattern of MAO isoforms clarified that MAO-A mRNA localizes to noradrenergic locus coeruleus neurons, providing a cellular basis for its distinct functional role from MAO-B.","evidence":"In situ hybridization histochemistry combined with enzyme radioautography in human post-mortem brain","pmids":["2089112"],"confidence":"Medium","gaps":["Only two brain nuclei examined in detail","Protein-level confirmation not performed in the same study","Developmental changes in expression pattern not addressed"]},{"year":1995,"claim":"The first genetic knockout proved that MAOA is essential for monoamine catabolism in vivo: MAOA-null mice showed dramatically elevated brain serotonin and norepinephrine, and pharmacological rescue with a serotonin synthesis inhibitor pinpointed serotonin excess as the driver of the aggressive behavioral phenotype.","evidence":"Transgenic knockout mouse model with HPLC neurochemical profiling and parachlorophenylalanine rescue","pmids":["7792602"],"confidence":"High","gaps":["Mechanism by which elevated serotonin causes aggression not defined at circuit level","Contribution of norepinephrine elevation to behavioral phenotype not isolated"]},{"year":1999,"claim":"Reciprocal comparison of MAOA-KO versus MAOB-KO mice resolved the long-standing question of isoform substrate specificity in vivo, confirming MAOA preferentially degrades serotonin and norepinephrine while MAOB preferentially degrades phenylethylamine.","evidence":"Homologous recombination knockout mice with neurochemical profiling of both isoforms","pmids":["10591056"],"confidence":"High","gaps":["Dopamine degradation appeared affected in both models, with relative contributions unresolved","Compensatory changes between isoforms during development not fully excluded"]},{"year":2006,"claim":"Demonstration that MAOA undergoes X-chromosome inactivation in human cells established that females are functionally mosaic for MAOA expression, with implications for interpreting sex-linked genetic association studies.","evidence":"Primary clonal fibroblast cultures with RFLP-based allelic expression analysis, confirmed independently by methylation profiling in skewed-XCI cells","pmids":["16890910","19684479"],"confidence":"Medium","gaps":["XCI status not confirmed in neurons or other tissue types","Whether XCI escape occurs in specific developmental windows not tested"]},{"year":2012,"claim":"Two convergent regulatory mechanisms for MAOA expression were established: promoter CpG methylation was shown to predict brain MAO-A activity by PET, and acute glucocorticoid/stress exposure was found to rapidly downregulate MAO-A protein and activity, revealing both epigenetic and hormonal control of enzyme levels.","evidence":"Bisulfite sequencing of blood DNA correlated with [¹¹C]clorgyline PET (methylation); [¹¹C]harmine PET under acute stress plus dexamethasone treatment of neuronal/glial cell lines (glucocorticoid regulation)","pmids":["22948232","23197705"],"confidence":"High","gaps":["Molecular mechanism of glucocorticoid-mediated MAOA downregulation (GR binding site, mRNA stability) not defined","Whether methylation changes are cause or consequence of activity differences not fully resolved"]},{"year":2015,"claim":"The discovery that cancer-associated fibroblasts activate a MAOA/mTOR/HIF-1α axis to drive prostate cancer EMT and invasion was among the first findings implicating MAOA's ROS-generating catalytic activity as a tumor-promoting mechanism in the stromal compartment.","evidence":"In vitro invasion assays with ROS measurement and pathway inhibition in fibroblast-cancer cell co-culture","pmids":["26499200"],"confidence":"Medium","gaps":["Pathway order established only by pharmacological inhibition without genetic epistasis","No in vivo validation of fibroblast-specific MAOA contribution"]},{"year":2017,"claim":"Identification of REST as a direct transcriptional repressor of MAOA, with derepressed MAOA driving ROS-dependent autophagy activation over apoptosis, placed MAOA in the neuroendocrine differentiation program of prostate cancer.","evidence":"ChIP and luciferase reporter assay for REST binding to MAOA promoter; ROS and autophagy/apoptosis assays with MAOA overexpression/inhibition","pmids":["28402333"],"confidence":"Medium","gaps":["REST–MAOA axis not validated in patient-derived neuroendocrine prostate cancer specimens","Whether autophagy activation is adaptive or cytotoxic in this context not determined"]},{"year":2018,"claim":"Multiple 2018 studies established MAOA as a node integrating cytokine, metabolic, and developmental signals in cancer: IL-13 induces MAOA via STAT6–15-LO–PPARγ in monocytes and cancer cells; prostate-specific MAOA deletion in Pten-KO mice reduced adenocarcinoma incidence and cancer stemness through PTEN/AKT; and promoter methylation was confirmed as functionally suppressive by reporter assays.","evidence":"siRNA/inhibitor pathway dissection in monocytes and A549 cells (IL-13); conditional double-KO mouse model with shRNA and pharmacological validation (Pten); methylated vs. unmethylated luciferase reporters (methylation)","pmids":["30021838","29844571","30169842"],"confidence":"High","gaps":["PPARγ binding site on MAOA promoter not mapped","Whether MAOA's tumor-promoting role in Pten-KO model is purely ROS-dependent or involves non-enzymatic functions not resolved"]},{"year":2019,"claim":"Meta-analysis confirmed the MAOA 5'-VNTR as a functional regulatory polymorphism with medium-to-large effect on enzyme activity, resolving prior conflicting reports, and pharmacological inhibitors were shown to suppress both AR and AR-V7 expression in prostate cancer cells.","evidence":"Systematic meta-analysis of VNTR-activity studies; MAOA activity assay and Western blot in enzalutamide-resistant prostate cancer cells","pmids":["31303260","30693539"],"confidence":"High","gaps":["Mechanism by which MAOA inhibition downregulates AR-V7 splice variant not defined","VNTR meta-analysis does not resolve tissue-specific effect sizes"]},{"year":2021,"claim":"Three major mechanistic advances were made: MAOA was shown to be the primary striatal dopamine-degrading enzyme in vivo; androgens were found to directly induce MAOA via AR binding to a novel intronic response element forming a positive feedback loop with Shh/Gli–YAP1; and MAOA was shown to drive perineural invasion through Twist1-dependent SEMA3C transcription activating PlexinA2/NRP1–cMET.","evidence":"In vivo voltammetry and GRABDA2m imaging with selective inhibitors (striatal DA); ChIP of AR at MAOA intronic element, co-IP of YAP1–AR, xenograft models (AR loop); PNI assay and orthotopic xenograft with gene silencing (perineural invasion)","pmids":["34244591","34167949","33420365"],"confidence":"High","gaps":["Whether the AR–MAOA feedback loop operates in castration-resistant disease in patients not confirmed","Structural basis for MAOA substrate preference for dopamine over other catecholamines in striatum not resolved"]},{"year":2023,"claim":"MAOA was found to physically interact with NDRG1 and suppress glycolysis via PI3K/AKT/mTOR inhibition in gastric cancer, and separately to mediate toxicant-induced tryptophan metabolism disruption through ROS–NFκB in trophoblasts, broadening MAOA's non-neuronal roles to metabolic regulation and reproductive toxicology.","evidence":"Co-immunoprecipitation and Seahorse metabolic assays in gastric cancer cells; clorgyline rescue and NFκB inhibitor experiments in JEG-3 trophoblasts with mouse intrauterine model","pmids":["37249744","37659542"],"confidence":"Medium","gaps":["MAOA–NDRG1 interaction awaits reciprocal validation and domain mapping","Whether MAOA's metabolic suppressive role in gastric cancer is enzymatic or scaffolding-dependent is unknown","Trophoblast findings from a single cell line require primary cell confirmation"]},{"year":2025,"claim":"Stromal MAOA was identified as an immune checkpoint mechanism: its inhibition elevated WNT5A production by cancer-associated fibroblasts, activating CD8+ T cells via Ca²⁺–NFATC1 signaling and synergizing with immune checkpoint blockade in vivo.","evidence":"Single-cell sequencing reanalysis, co-culture of stromal and immune cells, subcutaneous and humanized mouse models with MAOA inhibitor plus anti-PD-1","pmids":["40121032"],"confidence":"Medium","gaps":["WNT5A induction mechanism upon MAOA inhibition not defined (ROS-dependent or independent)","Whether this immunosuppressive role extends beyond prostate cancer stroma not tested","Clinical translatability of MAOA inhibitor–immunotherapy combination not established"]},{"year":null,"claim":"Major unresolved questions include: the structural basis for MAOA's substrate selectivity over MAOB in a physiological membrane context; whether MAOA's non-enzymatic protein interactions (e.g., NDRG1, YAP1–AR) represent independent functions or are coupled to its catalytic ROS output; and whether stromal MAOA inhibition can be therapeutically exploited to enhance anti-tumor immunity without adverse neuropsychiatric effects.","evidence":"","pmids":[],"confidence":"Low","gaps":["No solved structure of full-length membrane-bound human MAOA","Enzymatic vs. non-enzymatic contributions to cancer phenotypes not genetically separated","No clinical trial data for MAOA-targeted cancer therapy"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2,10,14,16]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,8]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,2,14,15,22]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1,2,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,4,5,6,7,8,9,21]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,14,21]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21]}],"complexes":[],"partners":["AR","TWIST1","NDRG1","YAP1","REST"],"other_free_text":[]},"mechanistic_narrative":"MAOA encodes a mitochondrial outer membrane flavoenzyme that catalyzes the oxidative deamination of monoamine neurotransmitters, with preferential activity toward serotonin and norepinephrine in the brain and primary responsibility for striatal dopamine degradation [PMID:7792602, PMID:10591056, PMID:34244591]. MAOA expression is regulated by a functional 5'-VNTR polymorphism, promoter CpG methylation that suppresses transcription, X-chromosome inactivation, acute glucocorticoid-mediated downregulation, and cytokine signaling through IL-13 via a STAT6–15-LO–PPARγ axis [PMID:31303260, PMID:22948232, PMID:30169842, PMID:23197705, PMID:30021838]. Beyond neurotransmitter catabolism, MAOA generates reactive oxygen species as a catalytic byproduct, and in prostate cancer this ROS production drives tumor-promoting programs including a reciprocal positive feedback loop with androgen receptor via Shh/Gli–YAP1, paracrine IL-6/STAT3 signaling through Twist1-dependent IL-6 transcription, perineural invasion via SEMA3C/PlexinA2/NRP1–cMET, cancer stemness through PTEN/AKT, and suppression of anti-tumor CD8+ T-cell immunity by limiting stromal WNT5A–Ca²⁺–NFATC1 activation [PMID:34167949, PMID:32066880, PMID:33420365, PMID:29844571, PMID:40121032]. Knockout mice lacking MAOA display markedly elevated brain serotonin with aggressive behavior that is rescued by serotonin synthesis inhibition, establishing MAOA as essential for monoamine homeostasis and behavioral regulation [PMID:7792602]."},"prefetch_data":{"uniprot":{"accession":"P21397","full_name":"Amine oxidase [flavin-containing] A","aliases":["Monoamine oxidase type A","MAO-A"],"length_aa":527,"mass_kda":59.7,"function":"Catalyzes the oxidative deamination of primary and some secondary amine such as neurotransmitters, with concomitant reduction of oxygen to hydrogen peroxide and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues (PubMed:18391214, PubMed:20493079, PubMed:24169519, PubMed:8316221). Preferentially oxidizes serotonin (PubMed:20493079, PubMed:24169519). Also catalyzes the oxidative deamination of kynuramine to 3-(2-aminophenyl)-3-oxopropanal that can spontaneously condense to 4-hydroxyquinoline (By similarity)","subcellular_location":"Mitochondrion outer membrane","url":"https://www.uniprot.org/uniprotkb/P21397/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAOA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MAOA","total_profiled":1310},"omim":[{"mim_id":"609685","title":"CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L","url":"https://www.omim.org/entry/609685"},{"mim_id":"609312","title":"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH","url":"https://www.omim.org/entry/609312"},{"mim_id":"606788","title":"ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON","url":"https://www.omim.org/entry/606788"},{"mim_id":"606416","title":"NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3","url":"https://www.omim.org/entry/606416"},{"mim_id":"604479","title":"SIRTUIN 1; SIRT1","url":"https://www.omim.org/entry/604479"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":206.3}],"url":"https://www.proteinatlas.org/search/MAOA"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P21397","domains":[{"cath_id":"3.50.50.60","chopping":"12-58_67-86_218-298_410-469","consensus_level":"high","plddt":98.5112,"start":12,"end":469},{"cath_id":"3.90.660.10","chopping":"112-209_489-519","consensus_level":"medium","plddt":98.0202,"start":112,"end":519},{"cath_id":"3.90.660.10","chopping":"303-396","consensus_level":"medium","plddt":98.349,"start":303,"end":396}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21397","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21397-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21397-F1-predicted_aligned_error_v6.png","plddt_mean":97.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAOA","jax_strain_url":"https://www.jax.org/strain/search?query=MAOA"},"sequence":{"accession":"P21397","fasta_url":"https://rest.uniprot.org/uniprotkb/P21397.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21397/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21397"}},"corpus_meta":[{"pmid":"7792602","id":"PMC_7792602","title":"Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7792602","citation_count":876,"is_preprint":false},{"pmid":"27803666","id":"PMC_27803666","title":"Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology.","date":"2016","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27803666","citation_count":295,"is_preprint":false},{"pmid":"24607445","id":"PMC_24607445","title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release.","date":"2014","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/24607445","citation_count":201,"is_preprint":false},{"pmid":"23786983","id":"PMC_23786983","title":"MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction.","date":"2013","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23786983","citation_count":193,"is_preprint":false},{"pmid":"19168625","id":"PMC_19168625","title":"Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19168625","citation_count":172,"is_preprint":false},{"pmid":"17592478","id":"PMC_17592478","title":"Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women.","date":"2007","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17592478","citation_count":152,"is_preprint":false},{"pmid":"26499200","id":"PMC_26499200","title":"Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling.","date":"2015","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26499200","citation_count":104,"is_preprint":false},{"pmid":"7969716","id":"PMC_7969716","title":"Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs.","date":"1994","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/7969716","citation_count":99,"is_preprint":false},{"pmid":"19625011","id":"PMC_19625011","title":"The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT.","date":"2009","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19625011","citation_count":99,"is_preprint":false},{"pmid":"17034017","id":"PMC_17034017","title":"Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17034017","citation_count":95,"is_preprint":false},{"pmid":"12815746","id":"PMC_12815746","title":"Association analysis of MAOA and COMT with neuroticism assessed by peers.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12815746","citation_count":94,"is_preprint":false},{"pmid":"24902785","id":"PMC_24902785","title":"Candidate genes for aggression and antisocial behavior: a meta-analysis of association studies of the 5HTTLPR and MAOA-uVNTR.","date":"2014","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24902785","citation_count":90,"is_preprint":false},{"pmid":"22948232","id":"PMC_22948232","title":"Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men.","date":"2012","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/22948232","citation_count":90,"is_preprint":false},{"pmid":"34244591","id":"PMC_34244591","title":"Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34244591","citation_count":88,"is_preprint":false},{"pmid":"20734127","id":"PMC_20734127","title":"Maltreatment, MAOA, and delinquency: sex differences in gene-environment interaction in a large population-based cohort of adolescents.","date":"2010","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20734127","citation_count":84,"is_preprint":false},{"pmid":"19804559","id":"PMC_19804559","title":"Early life stress, MAOA, and gene-environment interactions predict behavioral disinhibition in children.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19804559","citation_count":83,"is_preprint":false},{"pmid":"12555227","id":"PMC_12555227","title":"Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12555227","citation_count":77,"is_preprint":false},{"pmid":"33420365","id":"PMC_33420365","title":"MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33420365","citation_count":76,"is_preprint":false},{"pmid":"11443519","id":"PMC_11443519","title":"MAO-A and COMT polymorphisms and gene effects in narcolepsy.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11443519","citation_count":73,"is_preprint":false},{"pmid":"2193111","id":"PMC_2193111","title":"From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.","date":"1990","source":"Journal of neural transmission. Supplementum","url":"https://pubmed.ncbi.nlm.nih.gov/2193111","citation_count":72,"is_preprint":false},{"pmid":"21628708","id":"PMC_21628708","title":"MAOA, abuse exposure and antisocial behaviour: 30-year longitudinal study.","date":"2011","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/21628708","citation_count":72,"is_preprint":false},{"pmid":"31303260","id":"PMC_31303260","title":"Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2.","date":"2019","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31303260","citation_count":69,"is_preprint":false},{"pmid":"10402508","id":"PMC_10402508","title":"Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10402508","citation_count":69,"is_preprint":false},{"pmid":"19091581","id":"PMC_19091581","title":"New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.","date":"2008","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19091581","citation_count":65,"is_preprint":false},{"pmid":"10591056","id":"PMC_10591056","title":"MAO-A and -B gene knock-out mice exhibit distinctly different behavior.","date":"1999","source":"Neurobiology (Budapest, Hungary)","url":"https://pubmed.ncbi.nlm.nih.gov/10591056","citation_count":58,"is_preprint":false},{"pmid":"11353450","id":"PMC_11353450","title":"Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder.","date":"2001","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11353450","citation_count":57,"is_preprint":false},{"pmid":"30693539","id":"PMC_30693539","title":"Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.","date":"2019","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/30693539","citation_count":53,"is_preprint":false},{"pmid":"22297589","id":"PMC_22297589","title":"Moderating role of the MAOA genotype in antisocial behaviour.","date":"2012","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/22297589","citation_count":53,"is_preprint":false},{"pmid":"29844571","id":"PMC_29844571","title":"Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29844571","citation_count":52,"is_preprint":false},{"pmid":"10673777","id":"PMC_10673777","title":"Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10673777","citation_count":51,"is_preprint":false},{"pmid":"17192957","id":"PMC_17192957","title":"The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17192957","citation_count":51,"is_preprint":false},{"pmid":"28402333","id":"PMC_28402333","title":"MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28402333","citation_count":49,"is_preprint":false},{"pmid":"23067570","id":"PMC_23067570","title":"MAOA genotype, social exclusion and aggression: an experimental test of a gene-environment interaction.","date":"2012","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23067570","citation_count":48,"is_preprint":false},{"pmid":"30242487","id":"PMC_30242487","title":"Epigenetic signature of MAOA and MAOB genes in mental disorders.","date":"2018","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/30242487","citation_count":47,"is_preprint":false},{"pmid":"22911667","id":"PMC_22911667","title":"Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations.","date":"2012","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22911667","citation_count":46,"is_preprint":false},{"pmid":"18075472","id":"PMC_18075472","title":"The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18075472","citation_count":44,"is_preprint":false},{"pmid":"23170243","id":"PMC_23170243","title":"The effects of MAOA genotype, childhood trauma, and sex on trait and state-dependent aggression.","date":"2012","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23170243","citation_count":44,"is_preprint":false},{"pmid":"22030358","id":"PMC_22030358","title":"Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22030358","citation_count":43,"is_preprint":false},{"pmid":"29695771","id":"PMC_29695771","title":"Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer.","date":"2018","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29695771","citation_count":43,"is_preprint":false},{"pmid":"16856146","id":"PMC_16856146","title":"MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in indian children.","date":"2006","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16856146","citation_count":43,"is_preprint":false},{"pmid":"32066880","id":"PMC_32066880","title":"MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32066880","citation_count":42,"is_preprint":false},{"pmid":"7905288","id":"PMC_7905288","title":"Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.","date":"1993","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/7905288","citation_count":42,"is_preprint":false},{"pmid":"19357553","id":"PMC_19357553","title":"Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women.","date":"2009","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19357553","citation_count":42,"is_preprint":false},{"pmid":"22198720","id":"PMC_22198720","title":"Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia.","date":"2011","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22198720","citation_count":38,"is_preprint":false},{"pmid":"20485326","id":"PMC_20485326","title":"Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements.","date":"2010","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/20485326","citation_count":37,"is_preprint":false},{"pmid":"19120058","id":"PMC_19120058","title":"Effects of MAOA-genotype, alcohol consumption, and aging on violent behavior.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/19120058","citation_count":37,"is_preprint":false},{"pmid":"18430257","id":"PMC_18430257","title":"ADHD and Disruptive Behavior scores - associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents.","date":"2008","source":"BMC psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18430257","citation_count":35,"is_preprint":false},{"pmid":"37249744","id":"PMC_37249744","title":"MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.","date":"2023","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/37249744","citation_count":34,"is_preprint":false},{"pmid":"26620113","id":"PMC_26620113","title":"The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.","date":"2015","source":"Maturitas","url":"https://pubmed.ncbi.nlm.nih.gov/26620113","citation_count":34,"is_preprint":false},{"pmid":"25082653","id":"PMC_25082653","title":"Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders.","date":"2014","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/25082653","citation_count":34,"is_preprint":false},{"pmid":"30169842","id":"PMC_30169842","title":"Plasticity of Functional MAOA Gene Methylation in Acrophobia.","date":"2018","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30169842","citation_count":33,"is_preprint":false},{"pmid":"18726986","id":"PMC_18726986","title":"Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18726986","citation_count":33,"is_preprint":false},{"pmid":"26932718","id":"PMC_26932718","title":"Monoamine Oxidase A (MAOA) and Catechol-O-Methyltransferase (COMT) Gene Polymorphisms Interact with Maternal Parenting in Association with Adolescent Reactive Aggression but not Proactive Aggression: Evidence of Differential Susceptibility.","date":"2016","source":"Journal of youth and adolescence","url":"https://pubmed.ncbi.nlm.nih.gov/26932718","citation_count":32,"is_preprint":false},{"pmid":"22225631","id":"PMC_22225631","title":"Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells.","date":"2012","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/22225631","citation_count":31,"is_preprint":false},{"pmid":"32499684","id":"PMC_32499684","title":"The MAOA Gene Influences the Neural Response to Psychosocial Stress in the Human Brain.","date":"2020","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32499684","citation_count":29,"is_preprint":false},{"pmid":"16110245","id":"PMC_16110245","title":"Association study of a functional MAOA-uVNTR gene polymorphism and personality traits in Chinese young females.","date":"2005","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16110245","citation_count":29,"is_preprint":false},{"pmid":"37076041","id":"PMC_37076041","title":"Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37076041","citation_count":28,"is_preprint":false},{"pmid":"15088154","id":"PMC_15088154","title":"Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates.","date":"2004","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/15088154","citation_count":28,"is_preprint":false},{"pmid":"19382113","id":"PMC_19382113","title":"MAOA gene polymorphisms and response to mirtazapine in major depression.","date":"2009","source":"Human psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19382113","citation_count":28,"is_preprint":false},{"pmid":"8631685","id":"PMC_8631685","title":"maoB, a gene that encodes a positive regulator of the monoamine oxidase gene (maoA) in Escherichia coli.","date":"1996","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8631685","citation_count":28,"is_preprint":false},{"pmid":"2089112","id":"PMC_2089112","title":"Molecular neuroanatomy of MAO-A and MAO-B.","date":"1990","source":"Journal of neural transmission. Supplementum","url":"https://pubmed.ncbi.nlm.nih.gov/2089112","citation_count":27,"is_preprint":false},{"pmid":"22193458","id":"PMC_22193458","title":"MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22193458","citation_count":27,"is_preprint":false},{"pmid":"26103574","id":"PMC_26103574","title":"Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.","date":"2015","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26103574","citation_count":27,"is_preprint":false},{"pmid":"23197705","id":"PMC_23197705","title":"Convergent effects of acute stress and glucocorticoid exposure upon MAO-A in humans.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23197705","citation_count":27,"is_preprint":false},{"pmid":"30021838","id":"PMC_30021838","title":"Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30021838","citation_count":27,"is_preprint":false},{"pmid":"27821364","id":"PMC_27821364","title":"Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.","date":"2016","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/27821364","citation_count":27,"is_preprint":false},{"pmid":"19214141","id":"PMC_19214141","title":"Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19214141","citation_count":26,"is_preprint":false},{"pmid":"17007976","id":"PMC_17007976","title":"Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.","date":"2006","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17007976","citation_count":26,"is_preprint":false},{"pmid":"27984078","id":"PMC_27984078","title":"Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells.","date":"2016","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27984078","citation_count":26,"is_preprint":false},{"pmid":"21530215","id":"PMC_21530215","title":"Association of MAOA and COMT gene polymorphisms with palatable food intake in children.","date":"2011","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21530215","citation_count":25,"is_preprint":false},{"pmid":"17944904","id":"PMC_17944904","title":"Bad nature, bad nurture, and testimony regarding MAOA and SLC6A4 genotyping at murder trials.","date":"2007","source":"Journal of forensic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17944904","citation_count":25,"is_preprint":false},{"pmid":"32931665","id":"PMC_32931665","title":"The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32931665","citation_count":25,"is_preprint":false},{"pmid":"20421737","id":"PMC_20421737","title":"Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches.","date":"2010","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20421737","citation_count":24,"is_preprint":false},{"pmid":"24326626","id":"PMC_24326626","title":"The 2-repeat allele of the MAOA gene confers an increased risk for shooting and stabbing behaviors.","date":"2014","source":"The Psychiatric quarterly","url":"https://pubmed.ncbi.nlm.nih.gov/24326626","citation_count":23,"is_preprint":false},{"pmid":"26494873","id":"PMC_26494873","title":"Effects of the MAOA gene and levels of exposure to violence on antisocial outcomes.","date":"2015","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/26494873","citation_count":23,"is_preprint":false},{"pmid":"8678123","id":"PMC_8678123","title":"Mutational analysis of the human MAOA gene.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8678123","citation_count":23,"is_preprint":false},{"pmid":"34167949","id":"PMC_34167949","title":"Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34167949","citation_count":22,"is_preprint":false},{"pmid":"16192108","id":"PMC_16192108","title":"Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase.","date":"2005","source":"Xenobiotica; the fate of foreign compounds in biological systems","url":"https://pubmed.ncbi.nlm.nih.gov/16192108","citation_count":22,"is_preprint":false},{"pmid":"2089104","id":"PMC_2089104","title":"The expression of human MAO-A and B genes.","date":"1990","source":"Journal of neural transmission. Supplementum","url":"https://pubmed.ncbi.nlm.nih.gov/2089104","citation_count":22,"is_preprint":false},{"pmid":"29952131","id":"PMC_29952131","title":"Tobacco and cannabis use in college students are predicted by sex-dimorphic interactions between MAOA genotype and child abuse.","date":"2018","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29952131","citation_count":22,"is_preprint":false},{"pmid":"26481676","id":"PMC_26481676","title":"MAOA-VNTR polymorphism modulates context-dependent dopamine release and aggressive behavior in males.","date":"2015","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/26481676","citation_count":22,"is_preprint":false},{"pmid":"22351881","id":"PMC_22351881","title":"Association between a functional polymorphism in the MAOA gene and sudden infant death syndrome.","date":"2012","source":"Pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/22351881","citation_count":22,"is_preprint":false},{"pmid":"21826446","id":"PMC_21826446","title":"Association of positive and negative parenting behavior with childhood ADHD: interactions with offspring monoamine oxidase A (MAO-A) genotype.","date":"2012","source":"Journal of abnormal child psychology","url":"https://pubmed.ncbi.nlm.nih.gov/21826446","citation_count":21,"is_preprint":false},{"pmid":"29478144","id":"PMC_29478144","title":"Integration of transcriptomic and cytoarchitectonic data implicates a role for MAOA and TAC1 in the limbic-cortical network.","date":"2018","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/29478144","citation_count":21,"is_preprint":false},{"pmid":"10050962","id":"PMC_10050962","title":"Screen for MAOA mutations in target human groups.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10050962","citation_count":21,"is_preprint":false},{"pmid":"31448578","id":"PMC_31448578","title":"Emotional stability is associated with the MAOA promoter uVNTR polymorphism in women.","date":"2019","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/31448578","citation_count":20,"is_preprint":false},{"pmid":"16890910","id":"PMC_16890910","title":"Monoallelic expression of MAOA in skin fibroblasts.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16890910","citation_count":20,"is_preprint":false},{"pmid":"31314763","id":"PMC_31314763","title":"Association of MAOA genetic variants and resilience with psychosocial stress: A longitudinal study of Syrian refugees.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31314763","citation_count":20,"is_preprint":false},{"pmid":"20477771","id":"PMC_20477771","title":"MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence.","date":"2010","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/20477771","citation_count":20,"is_preprint":false},{"pmid":"17894408","id":"PMC_17894408","title":"Meta-study on association between the monoamine oxidase A gene (MAOA) and schizophrenia.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17894408","citation_count":19,"is_preprint":false},{"pmid":"27823806","id":"PMC_27823806","title":"The forensic use of behavioral genetics in criminal proceedings: Case of the MAOA-L genotype.","date":"2016","source":"International journal of law and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27823806","citation_count":19,"is_preprint":false},{"pmid":"27935229","id":"PMC_27935229","title":"Cortico-limbic connectivity in MAOA-L carriers is vulnerable to acute tryptophan depletion.","date":"2016","source":"Human brain mapping","url":"https://pubmed.ncbi.nlm.nih.gov/27935229","citation_count":18,"is_preprint":false},{"pmid":"11008877","id":"PMC_11008877","title":"Age-related changes of MAO-A and -B distribution in human and mouse brain.","date":"2000","source":"Neurobiology (Budapest, Hungary)","url":"https://pubmed.ncbi.nlm.nih.gov/11008877","citation_count":17,"is_preprint":false},{"pmid":"29222910","id":"PMC_29222910","title":"Associations Between MAOA-uVNTR Genotype, Maltreatment, MAOA Methylation, and Alcohol Consumption in Young Adult Males.","date":"2018","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/29222910","citation_count":17,"is_preprint":false},{"pmid":"19684479","id":"PMC_19684479","title":"MAOA and GYG2 are submitted to X chromosome inactivation in human fibroblasts.","date":"2009","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19684479","citation_count":17,"is_preprint":false},{"pmid":"30505241","id":"PMC_30505241","title":"Placental MAOA expression mediates prenatal stress effects on temperament in 12-month-olds.","date":"2018","source":"Infant and child development","url":"https://pubmed.ncbi.nlm.nih.gov/30505241","citation_count":15,"is_preprint":false},{"pmid":"35566238","id":"PMC_35566238","title":"Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35566238","citation_count":15,"is_preprint":false},{"pmid":"30414913","id":"PMC_30414913","title":"Early life stress and voluntary alcohol consumption in relation to Maoa methylation in male rats.","date":"2018","source":"Alcohol (Fayetteville, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30414913","citation_count":15,"is_preprint":false},{"pmid":"40121032","id":"PMC_40121032","title":"Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.","date":"2025","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40121032","citation_count":14,"is_preprint":false},{"pmid":"37659542","id":"PMC_37659542","title":"Triphenyl phosphate disrupts placental tryptophan metabolism by activating MAOA/ROS/NFκB.","date":"2023","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/37659542","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48703,"output_tokens":5445,"usd":0.113892},"stage2":{"model":"claude-opus-4-6","input_tokens":9065,"output_tokens":3660,"usd":0.205237},"total_usd":0.319129,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"MAOA encodes a monoamine oxidase enzyme that degrades serotonin and norepinephrine in the brain; knockout mice lacking MAOA show up to 9-fold elevated brain serotonin and 2-fold elevated norepinephrine, demonstrating MAOA's essential role in monoamine catabolism. The behavioral phenotype (trembling, fearfulness, aggression) was reversed by the serotonin synthesis inhibitor parachlorophenylalanine, confirming serotonin elevation as the mechanistic driver.\",\n      \"method\": \"Transgenic knockout mouse model with neurochemical measurement (HPLC) and pharmacological rescue (parachlorophenylalanine)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo KO with defined neurochemical phenotype, pharmacological rescue, replicated across the field\",\n      \"pmids\": [\"7792602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MAO-A preferentially oxidizes serotonin (5-HT) and norepinephrine (NE), whereas MAO-B preferentially oxidizes phenylethylamine (PEA). MAO-A KO mice have elevated brain levels of 5-HT, NE, and DA and manifest aggression, while MAO-B KO mice show only elevated PEA without aggression, establishing distinct substrate specificities and physiological roles for the two isoforms.\",\n      \"method\": \"Homologous recombination KO mice with neurochemical profiling\",\n      \"journal\": \"Neurobiology (Budapest)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal KO models with distinct neurochemical and behavioral phenotypes\",\n      \"pmids\": [\"10591056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAO-A, but not MAO-B, is the primary enzyme responsible for striatal dopamine degradation in vivo, as shown by in vivo electrochemical monitoring and ex vivo fluorescence imaging. In contrast, MAO-B (not MAO-A) is responsible for astrocytic GABA synthesis mediating tonic inhibitory currents in the rat striatum.\",\n      \"method\": \"In vivo fast-scan cyclic voltammetry, multiple-cyclic square wave voltammetry, ex vivo GRABDA2m fluorescence imaging, and whole-cell patch-clamp electrophysiology\",\n      \"journal\": \"Experimental & Molecular Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal in vivo and ex vivo methods with selective inhibitors distinguishing MAO-A vs MAO-B contributions\",\n      \"pmids\": [\"34244591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAOA promotes prostate cancer perineural invasion by activating SEMA3C transcription in a Twist1-dependent manner; SEMA3C then stimulates cMET via autocrine/paracrine interaction with co-activated PlexinA2 and NRP1 receptors to facilitate invasion.\",\n      \"method\": \"In vitro PNI assay, orthotopic xenograft model, gene silencing, mechanistic pathway analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo models with defined pathway (Twist1→SEMA3C→PlexinA2/NRP1→cMET) and functional rescue\",\n      \"pmids\": [\"33420365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAOA and androgen receptor (AR) form a positive feedback loop in prostate cancer: androgens induce MAOA transcription via direct AR binding to a novel intronic androgen response element, and MAOA in turn promotes AR transcriptional activity through upregulation of Shh/Gli-YAP1 signaling and nuclear YAP1-AR interactions.\",\n      \"method\": \"ChIP assay (AR binding to MAOA intronic element), gene silencing, xenograft mouse models, co-immunoprecipitation, luciferase reporter assays\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including ChIP, co-IP, reporter assays, and in vivo validation\",\n      \"pmids\": [\"34167949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MAOA in stromal fibroblasts elevates reactive oxygen species production, triggers IL-6 activation through direct Twist1 binding to a conserved E-box element in the IL-6 promoter, and promotes prostate cancer cell growth via paracrine IL-6/STAT3 signaling. STAT3 then transcriptionally activates CD44 to promote cancer stemness.\",\n      \"method\": \"ChIP assay (Twist1 binding to IL-6 promoter E-box), co-culture systems, in vivo xenograft, tissue microarray, gene silencing\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-validated transcriptional mechanism with in vivo confirmation and clinical tissue correlation\",\n      \"pmids\": [\"32066880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Prostate-specific deletion of MAOA in a Pten-KO mouse model significantly reduced prostate cancer incidence, AKT phosphorylation, Ki67 expression, and cancer stem cell markers (OCT4, NANOG, CD44, α2β1, CD133, HIF-1α), establishing that MAOA promotes adenocarcinoma development by supporting cell proliferation and maintenance of cancer stem cells through the PTEN/AKT axis.\",\n      \"method\": \"Conditional Pten/MAOA double-KO mouse model, shRNA knockdown, colony/spheroid formation assays, MAOA inhibitor treatment\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with multiple mechanistic readouts and pharmacological validation\",\n      \"pmids\": [\"29844571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cancer-associated fibroblasts (CAFs) induce prostate cancer cell EMT and invasion through a MAOA/mTOR/HIF-1α signaling pathway that exploits reactive oxygen species (ROS). Curcumin abrogated CAF-induced invasion by inhibiting this MAOA/mTOR/HIF-1α pathway and reducing ROS production.\",\n      \"method\": \"In vitro invasion assays, ROS measurement, pathway inhibition, siRNA knockdown\",\n      \"journal\": \"International Journal of Oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — in vitro mechanistic pathway analysis without full genetic rescue or in vivo validation of pathway order\",\n      \"pmids\": [\"26499200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAOA is a direct target gene of the transcriptional repressor REST. ROS produced by overexpressed MAOA inhibits apoptosis and activates autophagy in neuroendocrine-differentiated prostate cancer cells, placing MAOA downstream of REST and upstream of the autophagy/apoptosis decision.\",\n      \"method\": \"ChIP, luciferase reporter assay, ROS measurement, MAOA overexpression/inhibition, autophagy/apoptosis assays\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-validated REST→MAOA regulation with functional ROS/autophagy mechanistic follow-up\",\n      \"pmids\": [\"28402333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MAOA inhibitors (clorgyline and phenelzine) decrease MAOA enzymatic activity in prostate cancer cells, suppress proliferation, and clorgyline decreases expression of both full-length AR and AR splice variant 7 (AR-V7), with additive growth inhibition when combined with enzalutamide.\",\n      \"method\": \"MAOA activity assay, cell viability assay, Western blot for AR/AR-V7, enzalutamide-resistant cell line model\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct enzyme activity measurement combined with defined molecular endpoint (AR/AR-V7 reduction) in multiple cell line contexts\",\n      \"pmids\": [\"30693539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Methylation of the MAOA promoter CpG region (measured in blood cells) is robustly associated with brain MAO-A activity levels as measured by PET, and the VNTR genotype does not independently predict brain MAO-A activity, suggesting promoter methylation is a key epigenetic regulator of MAOA expression and activity.\",\n      \"method\": \"Bisulfite sequencing of MAOA promoter from blood DNA combined with [(11)C]clorgyline PET imaging of brain MAO-A activity in healthy males\",\n      \"journal\": \"Epigenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal methods (epigenetic sequencing + PET quantification) with robust association linking blood methylation to brain enzyme activity\",\n      \"pmids\": [\"22948232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MAOA promoter methylation is functionally relevant: methylated MAOA promoter constructs show decreased reporter gene activity compared to unmethylated constructs. Methylation levels increase after exposure therapy for acrophobia and correlate with treatment response, demonstrating dynamic, functionally relevant epigenetic regulation of MAOA.\",\n      \"method\": \"Bisulfite sequencing of blood DNA before/after therapy, luciferase-based reporter gene assay with methylated vs. unmethylated constructs\",\n      \"journal\": \"International Journal of Neuropsychopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional reporter assay demonstrates mechanistic link between methylation and transcription, with in vivo correlation\",\n      \"pmids\": [\"30169842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Acute psychosocial stress and acute glucocorticoid (dexamethasone) exposure rapidly decrease MAO-A activity and protein levels in neuronal and glial cell lines, and reduce MAO-A binding in 10 of 11 brain regions by PET, establishing a convergent regulatory mechanism whereby acute stress/glucocorticoids suppress MAOA expression.\",\n      \"method\": \"[(11)C]harmine PET in humans under acute stress; Western blot and [(14)C]-5-HT metabolism assay in human neuronal/glial cell lines after dexamethasone\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — convergent human PET imaging and in vitro biochemical assays with direct activity and protein measurements\",\n      \"pmids\": [\"23197705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-6/IL-6R signaling inhibits MAO-A activity and expression in hypoxic breast cancer cells; reciprocally, elevated MAO-A suppresses tumor angiogenesis and invasion. Inhibition of IL-6R or siRNA knockdown of IL-6R increased MAO-A activity and inhibited VEGF, MMPs, and EMT markers, placing MAO-A downstream of IL-6R and upstream of the pro-tumorigenic ROS pathway.\",\n      \"method\": \"In vitro siRNA knockdown, IL-6R inhibitor treatment, MAO-A activity assay, invasion/angiogenesis assays, in vivo tumor models, clinical specimen IHC\",\n      \"journal\": \"British Journal of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro and in vivo methods establishing IL-6R→MAO-A regulatory relationship with functional angiogenesis/invasion readouts\",\n      \"pmids\": [\"29695771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-13 stimulates MAOA gene expression and enzymatic activity in primary human monocytes and A549 lung carcinoma cells through a pathway involving STAT1/3/6, EGR1, CREB, and 15-lipoxygenase (15-LO); 15-LO then drives MAOA expression via PPARγ in a STAT6-dependent manner. This IL-13-STAT6-15-LO-PPARγ axis controls MAOA-dependent ROS generation and cell migration.\",\n      \"method\": \"siRNA knockdown, selective inhibitors, qPCR, MAOA activity assay, ROS measurement, migration assay in primary monocytes and cancer cells\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic pathway dissection with siRNA and inhibitors, activity assays, and functional readouts across two cell types\",\n      \"pmids\": [\"30021838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MAOA interacts physically with NDRG1 and suppresses glycolysis/Warburg effect in gastric cancer cells through inhibition of the PI3K/AKT/mTOR pathway; loss of MAOA facilitates gastric cancer progression.\",\n      \"method\": \"Co-immunoprecipitation (MAOA-NDRG1 interaction), Western blot for PI3K/AKT/mTOR, Seahorse metabolic assay, siRNA knockdown, in vivo mouse model\",\n      \"journal\": \"Cellular Oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP validates physical interaction; Seahorse and pathway analysis establish metabolic mechanism\",\n      \"pmids\": [\"37249744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Systematic meta-analysis confirmed that the MAOA 5' VNTR polymorphism has a robust and medium-to-large effect on MAOA enzyme activity, establishing this promoter variant as a functional regulatory polymorphism that determines the level of MAO-A protein activity.\",\n      \"method\": \"Systematic review and meta-analysis of studies measuring polymorphism effects on enzyme expression, abundance, and activity\",\n      \"journal\": \"Biological Psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — meta-analysis of multiple functional studies with enzyme activity as the direct endpoint; strong preponderance of evidence\",\n      \"pmids\": [\"31303260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MAOA is subject to X chromosome inactivation in human female fibroblasts, resulting in monoallelic expression; this was demonstrated using primary clonal cell cultures with RFLP-based allelic expression analysis.\",\n      \"method\": \"Primary clonal cell culture, RFLP allelic expression analysis\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct allele-specific expression assay in primary human cells\",\n      \"pmids\": [\"16890910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MAOA is subject to X chromosome inactivation (not escape) in normal human fibroblasts, with monoallelic expression confirmed by allele-specific expression analysis combined with promoter DNA methylation profiling in cells with skewed X inactivation.\",\n      \"method\": \"Allele-specific expression using skewed X-inactivation fibroblasts, methylation analysis of MAOA 5' end\",\n      \"journal\": \"Epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two complementary methods (expression + methylation) in normal human cells, confirming XCI status\",\n      \"pmids\": [\"19684479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"In situ hybridization histochemistry showed that locus coeruleus neurons in human brain express MAO-A mRNA, while raphe neurons express MAO-B mRNA, establishing a neuroanatomical basis for the distinct functional roles of the two isoforms.\",\n      \"method\": \"In situ hybridization histochemistry combined with enzyme radioautography in human post-mortem brain\",\n      \"journal\": \"Journal of Neural Transmission (Supplementum)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cellular localization of mRNA in human brain with histochemical validation\",\n      \"pmids\": [\"2089112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ApoE4 isoform expression in C6 glioma cells reduces MAOA mRNA expression compared to ApoE3, resulting in elevated serotonin (substrate for MAOA) and consequently increased melatonin biosynthesis, establishing a regulatory link between ApoE genotype and MAOA expression levels.\",\n      \"method\": \"Stable ApoE isoform expression in C6 cells, melatonin ELISA, Western blot, qRT-PCR of MAOA/MAOB\",\n      \"journal\": \"Journal of Pineal Research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single cell line model, indirect pathway inference, no direct MAOA enzymatic activity measured\",\n      \"pmids\": [\"22225631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Inhibition of stromal MAOA increases WNT5A production in cancer-associated fibroblasts, which activates CD8+ T cell cytotoxic capacity through the Ca2+-NFATC1 signaling pathway, identifying a mechanism by which stromal MAOA suppresses anti-tumor immunity in prostate cancer.\",\n      \"method\": \"Single-cell sequencing reanalysis, in vitro co-culture of stromal and immune cells, subcutaneous and humanized mouse models, MAOA inhibitor + immune checkpoint inhibitor combination\",\n      \"journal\": \"Journal for Immunotherapy of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo mechanistic data with defined pathway (MAOA inhibition→WNT5A→Ca2+-NFATC1→CD8+ T cell activation)\",\n      \"pmids\": [\"40121032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TPhP (triphenyl phosphate) activates MAOA in trophoblast cells, leading to increased ROS production that activates NFκB, which in turn disrupts tryptophan metabolism by inhibiting the tryptophan-serotonin pathway and activating the kynurenine pathway. MAOA inhibitor clorgyline or antioxidant N-acetylcysteine mitigated these effects.\",\n      \"method\": \"JEG-3 trophoblast cell line treatment, MAOA inhibitor (clorgyline) and NFκB inhibitor (sulfasalazine) rescue experiments, ROS assay, qPCR, Western blot; mouse intrauterine exposure model\",\n      \"journal\": \"Science of the Total Environment\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition experiments with multiple pathway markers establish MAOA→ROS→NFκB→tryptophan metabolism axis\",\n      \"pmids\": [\"37659542\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAOA is a mitochondrial flavoenzyme that oxidatively deaminates monoamine neurotransmitters (preferentially serotonin and norepinephrine, and dopamine in the striatum), generating H2O2 as a byproduct; its expression is regulated by promoter VNTR polymorphism and CpG methylation (which functionally suppresses transcription), by glucocorticoid/acute stress exposure (acutely downregulating activity), by IL-13 via a STAT6-15-LO-PPARγ axis, and by androgens through direct AR binding to an intronic response element; in prostate cancer it drives a reciprocal feedback loop with AR (via Shh/Gli-YAP1), promotes stromal IL-6/STAT3 paracrine signaling through Twist1-dependent transcription, mediates perineural invasion via SEMA3C/PlexinA2/NRP1-cMET, and suppresses anti-tumor immunity by limiting stromal WNT5A-Ca2+-NFATC1-CD8+ T cell activation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MAOA encodes a mitochondrial outer membrane flavoenzyme that catalyzes the oxidative deamination of monoamine neurotransmitters, with preferential activity toward serotonin and norepinephrine in the brain and primary responsibility for striatal dopamine degradation [PMID:7792602, PMID:10591056, PMID:34244591]. MAOA expression is regulated by a functional 5'-VNTR polymorphism, promoter CpG methylation that suppresses transcription, X-chromosome inactivation, acute glucocorticoid-mediated downregulation, and cytokine signaling through IL-13 via a STAT6–15-LO–PPARγ axis [PMID:31303260, PMID:22948232, PMID:30169842, PMID:23197705, PMID:30021838]. Beyond neurotransmitter catabolism, MAOA generates reactive oxygen species as a catalytic byproduct, and in prostate cancer this ROS production drives tumor-promoting programs including a reciprocal positive feedback loop with androgen receptor via Shh/Gli–YAP1, paracrine IL-6/STAT3 signaling through Twist1-dependent IL-6 transcription, perineural invasion via SEMA3C/PlexinA2/NRP1–cMET, cancer stemness through PTEN/AKT, and suppression of anti-tumor CD8+ T-cell immunity by limiting stromal WNT5A–Ca²⁺–NFATC1 activation [PMID:34167949, PMID:32066880, PMID:33420365, PMID:29844571, PMID:40121032]. Knockout mice lacking MAOA display markedly elevated brain serotonin with aggressive behavior that is rescued by serotonin synthesis inhibition, establishing MAOA as essential for monoamine homeostasis and behavioral regulation [PMID:7792602].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing the neuroanatomical expression pattern of MAO isoforms clarified that MAO-A mRNA localizes to noradrenergic locus coeruleus neurons, providing a cellular basis for its distinct functional role from MAO-B.\",\n      \"evidence\": \"In situ hybridization histochemistry combined with enzyme radioautography in human post-mortem brain\",\n      \"pmids\": [\"2089112\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only two brain nuclei examined in detail\", \"Protein-level confirmation not performed in the same study\", \"Developmental changes in expression pattern not addressed\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"The first genetic knockout proved that MAOA is essential for monoamine catabolism in vivo: MAOA-null mice showed dramatically elevated brain serotonin and norepinephrine, and pharmacological rescue with a serotonin synthesis inhibitor pinpointed serotonin excess as the driver of the aggressive behavioral phenotype.\",\n      \"evidence\": \"Transgenic knockout mouse model with HPLC neurochemical profiling and parachlorophenylalanine rescue\",\n      \"pmids\": [\"7792602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which elevated serotonin causes aggression not defined at circuit level\", \"Contribution of norepinephrine elevation to behavioral phenotype not isolated\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Reciprocal comparison of MAOA-KO versus MAOB-KO mice resolved the long-standing question of isoform substrate specificity in vivo, confirming MAOA preferentially degrades serotonin and norepinephrine while MAOB preferentially degrades phenylethylamine.\",\n      \"evidence\": \"Homologous recombination knockout mice with neurochemical profiling of both isoforms\",\n      \"pmids\": [\"10591056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dopamine degradation appeared affected in both models, with relative contributions unresolved\", \"Compensatory changes between isoforms during development not fully excluded\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstration that MAOA undergoes X-chromosome inactivation in human cells established that females are functionally mosaic for MAOA expression, with implications for interpreting sex-linked genetic association studies.\",\n      \"evidence\": \"Primary clonal fibroblast cultures with RFLP-based allelic expression analysis, confirmed independently by methylation profiling in skewed-XCI cells\",\n      \"pmids\": [\"16890910\", \"19684479\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"XCI status not confirmed in neurons or other tissue types\", \"Whether XCI escape occurs in specific developmental windows not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Two convergent regulatory mechanisms for MAOA expression were established: promoter CpG methylation was shown to predict brain MAO-A activity by PET, and acute glucocorticoid/stress exposure was found to rapidly downregulate MAO-A protein and activity, revealing both epigenetic and hormonal control of enzyme levels.\",\n      \"evidence\": \"Bisulfite sequencing of blood DNA correlated with [¹¹C]clorgyline PET (methylation); [¹¹C]harmine PET under acute stress plus dexamethasone treatment of neuronal/glial cell lines (glucocorticoid regulation)\",\n      \"pmids\": [\"22948232\", \"23197705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of glucocorticoid-mediated MAOA downregulation (GR binding site, mRNA stability) not defined\", \"Whether methylation changes are cause or consequence of activity differences not fully resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The discovery that cancer-associated fibroblasts activate a MAOA/mTOR/HIF-1α axis to drive prostate cancer EMT and invasion was among the first findings implicating MAOA's ROS-generating catalytic activity as a tumor-promoting mechanism in the stromal compartment.\",\n      \"evidence\": \"In vitro invasion assays with ROS measurement and pathway inhibition in fibroblast-cancer cell co-culture\",\n      \"pmids\": [\"26499200\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pathway order established only by pharmacological inhibition without genetic epistasis\", \"No in vivo validation of fibroblast-specific MAOA contribution\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of REST as a direct transcriptional repressor of MAOA, with derepressed MAOA driving ROS-dependent autophagy activation over apoptosis, placed MAOA in the neuroendocrine differentiation program of prostate cancer.\",\n      \"evidence\": \"ChIP and luciferase reporter assay for REST binding to MAOA promoter; ROS and autophagy/apoptosis assays with MAOA overexpression/inhibition\",\n      \"pmids\": [\"28402333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"REST–MAOA axis not validated in patient-derived neuroendocrine prostate cancer specimens\", \"Whether autophagy activation is adaptive or cytotoxic in this context not determined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Multiple 2018 studies established MAOA as a node integrating cytokine, metabolic, and developmental signals in cancer: IL-13 induces MAOA via STAT6–15-LO–PPARγ in monocytes and cancer cells; prostate-specific MAOA deletion in Pten-KO mice reduced adenocarcinoma incidence and cancer stemness through PTEN/AKT; and promoter methylation was confirmed as functionally suppressive by reporter assays.\",\n      \"evidence\": \"siRNA/inhibitor pathway dissection in monocytes and A549 cells (IL-13); conditional double-KO mouse model with shRNA and pharmacological validation (Pten); methylated vs. unmethylated luciferase reporters (methylation)\",\n      \"pmids\": [\"30021838\", \"29844571\", \"30169842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PPARγ binding site on MAOA promoter not mapped\", \"Whether MAOA's tumor-promoting role in Pten-KO model is purely ROS-dependent or involves non-enzymatic functions not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Meta-analysis confirmed the MAOA 5'-VNTR as a functional regulatory polymorphism with medium-to-large effect on enzyme activity, resolving prior conflicting reports, and pharmacological inhibitors were shown to suppress both AR and AR-V7 expression in prostate cancer cells.\",\n      \"evidence\": \"Systematic meta-analysis of VNTR-activity studies; MAOA activity assay and Western blot in enzalutamide-resistant prostate cancer cells\",\n      \"pmids\": [\"31303260\", \"30693539\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which MAOA inhibition downregulates AR-V7 splice variant not defined\", \"VNTR meta-analysis does not resolve tissue-specific effect sizes\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Three major mechanistic advances were made: MAOA was shown to be the primary striatal dopamine-degrading enzyme in vivo; androgens were found to directly induce MAOA via AR binding to a novel intronic response element forming a positive feedback loop with Shh/Gli–YAP1; and MAOA was shown to drive perineural invasion through Twist1-dependent SEMA3C transcription activating PlexinA2/NRP1–cMET.\",\n      \"evidence\": \"In vivo voltammetry and GRABDA2m imaging with selective inhibitors (striatal DA); ChIP of AR at MAOA intronic element, co-IP of YAP1–AR, xenograft models (AR loop); PNI assay and orthotopic xenograft with gene silencing (perineural invasion)\",\n      \"pmids\": [\"34244591\", \"34167949\", \"33420365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the AR–MAOA feedback loop operates in castration-resistant disease in patients not confirmed\", \"Structural basis for MAOA substrate preference for dopamine over other catecholamines in striatum not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"MAOA was found to physically interact with NDRG1 and suppress glycolysis via PI3K/AKT/mTOR inhibition in gastric cancer, and separately to mediate toxicant-induced tryptophan metabolism disruption through ROS–NFκB in trophoblasts, broadening MAOA's non-neuronal roles to metabolic regulation and reproductive toxicology.\",\n      \"evidence\": \"Co-immunoprecipitation and Seahorse metabolic assays in gastric cancer cells; clorgyline rescue and NFκB inhibitor experiments in JEG-3 trophoblasts with mouse intrauterine model\",\n      \"pmids\": [\"37249744\", \"37659542\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MAOA–NDRG1 interaction awaits reciprocal validation and domain mapping\", \"Whether MAOA's metabolic suppressive role in gastric cancer is enzymatic or scaffolding-dependent is unknown\", \"Trophoblast findings from a single cell line require primary cell confirmation\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Stromal MAOA was identified as an immune checkpoint mechanism: its inhibition elevated WNT5A production by cancer-associated fibroblasts, activating CD8+ T cells via Ca²⁺–NFATC1 signaling and synergizing with immune checkpoint blockade in vivo.\",\n      \"evidence\": \"Single-cell sequencing reanalysis, co-culture of stromal and immune cells, subcutaneous and humanized mouse models with MAOA inhibitor plus anti-PD-1\",\n      \"pmids\": [\"40121032\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"WNT5A induction mechanism upon MAOA inhibition not defined (ROS-dependent or independent)\", \"Whether this immunosuppressive role extends beyond prostate cancer stroma not tested\", \"Clinical translatability of MAOA inhibitor–immunotherapy combination not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include: the structural basis for MAOA's substrate selectivity over MAOB in a physiological membrane context; whether MAOA's non-enzymatic protein interactions (e.g., NDRG1, YAP1–AR) represent independent functions or are coupled to its catalytic ROS output; and whether stromal MAOA inhibition can be therapeutically exploited to enhance anti-tumor immunity without adverse neuropsychiatric effects.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No solved structure of full-length membrane-bound human MAOA\", \"Enzymatic vs. non-enzymatic contributions to cancer phenotypes not genetically separated\", \"No clinical trial data for MAOA-targeted cancer therapy\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2, 10, 14, 16]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 2, 14, 15, 22]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1, 2, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 4, 5, 6, 7, 8, 9, 21]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 14, 21]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"AR\",\n      \"TWIST1\",\n      \"NDRG1\",\n      \"YAP1\",\n      \"REST\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}